Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Mesh vs. no mesh: which bladder prolapse surgery holds up better over time?

NCT ID NCT02255994

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 75 women who had surgery for bladder prolapse (a condition where the bladder bulges into the vagina). It compared two techniques: one using a mesh support and one without. The goal was to see which method works better over 5 to 8 years, focusing on whether the prolapse comes back and any complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

75 people

The number who actually took part.

Start date

Oct 2014

Finished

Dec 2015

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The patient must have given her informed and signed consent * The patient must be insured or beneficiary of a health insurance plan * Patient included in, randomized and analysed in the PROCURE study (NCT00153257) Exclusion Criteria: * The patient is under judicial protection, under tutorship or curatorship * The patient refuses to sign the consent * It is impossible to correctly inform the patient * Patient not included in the PROCURE study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cystocele are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • APHP - Centre Hospitalier Universitaire de Bicêtre

    Le Kremlin-Bicêtre, 94275, France

  • APHP - Hôpital Antoine Beclere

    Clamart, 92141, France

  • APHP - Hôpital Beaujon

    Clichy, 92110, France

  • CH d'Issoire - Centre Hospitalier Paul Ardier

    Issoire, 63503, France

  • CH d'Orange - Hôpital Louis Giorgi

    Orange, 84106, France

  • CH de Chartres - Hôpital Louis Pasteur

    Le Coudray, 28630, France

  • CH de la Rochelle

    La Rochelle, 17019, France

  • CHRU de Nîmes - Hôpital Universitaire Carémeau

    Nîmes, 30029, France

  • CHU de Clermont Ferrand - Hôpital Estaing

    Clermont-Ferrand, 63003, France

  • CHU de Rouen - Hôpital Charles Nicolle

    Rouen, 76031, France

  • Clinique Champeau

    Béziers, 34500, France

  • Clinique Mutualiste La Sagesse

    Rennes, 35000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.